Epirus, Ranbaxy win India approval for arthritis drug copy

Sept 15 (Reuters) - Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year.